Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neoplasms × lanreotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neuroendocrine Tumors 2 Acromegaly 2 Pituitary Neoplasms 1 Neuroendocrine Tumour With Carcinoid Symptoms 1 Neoplasms 1 Gigantism 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

Dexamethasone 6 Oxycodone 5 Propofol 4 Epoetin Alfa 4 Zoledronic Acid 3 Sevoflurane 3 Palonosetron 3 Everolimus 3 Cholecalciferol 3 Aspirin 3 peginterferon alfa-2a 2 edoxaban 2 apixaban 2 apatinib 2 Vitamin B 12 2 Vancomycin 2 Tobacco Use Cessation Devices 2 Tablets 2 Surgical Procedures, Operative 2 Saline Solution 2 Rivaroxaban 2 Ondansetron 2 Octreotide 2 Naloxone 2 Morphine 2 Metoclopramide 2 Meropenem 2 Lidocaine 2 Lenograstim 2 Ipilimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00627796 2008-03-03

ATG1line

Federico II University

Phase 4 Completed

Acromegaly, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡